With its renewed focus on winning market share, Medtronic estimates Mazor X placements outpaced Globus Medical's ExcelsiusGPS by a factor of 1.5 in 3Q20.
The company grew +3.6% for their fiscal 1Q21, however the second wave of rapid COVID spread has significantly reduced case volumes through November.
As a part of Johnson & Johnson's Virtual Medical Device Update, DePuy Synthes laid out its vision for the future of orthopedics.
The company rebounded sequentially in 3Q20 while sharpening its focus on digital surgery as a strategic initiative with the acquisition of Holo Surgical.
The company's MACI revenue grew +18.2% in 3Q20 while record numbers of new biopsies point toward a sequential step up in fourth quarter revenue.
The company grew 7% in 3Q20 as growth in U.S. trauma sales more than offset continuing COVID-related challenges in international markets.
The company's joint replacement business grew over 9% in 3Q20 as it prepares to enter the high-growth foot and ankle joint replacement market.
Despite gaining market share in Japan, the company's sales dropped by double-digits for the third consecutive quarter due to COVID and price reductions.
More than a year after announcing its intention to acquire Wright Medical for $5.4 billion, Stryker today completed the purchase.
The company grew +8.3% in 3Q20 due to its new product cadence, contracting wins in large health systems and geographic expansion of its revenue footprint.